MARKET

XAIR

XAIR

Beyond Air Inc
NASDAQ
0.3710
0.0000
0.00%
After Hours: 0.3802 +0.0092 +2.48% 19:18 06/15 EDT
OPEN
0.3769
PREV CLOSE
0.3710
HIGH
0.4000
LOW
0.3659
VOLUME
163.51K
TURNOVER
--
52 WEEK HIGH
5.84
52 WEEK LOW
0.3511
MARKET CAP
4.71M
P/E (TTM)
-0.0684
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XAIR last week (0608-0612)?
Weekly Report · 13h ago
Weekly Report: what happened at XAIR last week (0601-0605)?
Weekly Report · 06/08 10:14
Beyond Air Plans Reverse Split to Maintain Nasdaq Listing
TipRanks · 06/01 22:37
Beyond Air wins Nasdaq panel reprieve, must regain $1 bid price by July 31
PUBT · 06/01 20:35
Beyond Air Granted Nasdaq Panel Extension To Regain Compliance By July 31
Benzinga · 06/01 12:08
Beyond Air schedules shareholder meeting on reverse stock split proposal
PUBT · 06/01 12:06
BEYOND AIR RECEIVES NASDAQ HEARING PANEL DECISION GRANTING CONTINUED LISTING
Reuters · 06/01 12:00
Weekly Report: what happened at XAIR last week (0525-0529)?
Weekly Report · 06/01 10:18
More
About XAIR
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.

Webull offers Beyond Air Inc stock information, including NASDAQ: XAIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XAIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XAIR stock methods without spending real money on the virtual paper trading platform.